Statistics
Publications
3
Citations
59
H-Index
3
Active since
2011
Bo-Reum Kim is an author at Catholic University of Korea specializing in molecular oncology, oncology, and medicine.
Publications per year
2011–2023
3
3
TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently
Han Sun Kim, Bo-Reum Kim, Thien T. P. Dao et al. · Blood Advances · 2023 · 33 citations · Full text
Medicine, Oncology, Pharmacology +17
1–3 of 3